D Plocová

907 total citations
19 papers, 797 citations indexed

About

D Plocová is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, D Plocová has authored 19 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in D Plocová's work include Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). D Plocová is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), RNA Interference and Gene Delivery (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). D Plocová collaborates with scholars based in Czechia, Belarus and Belgium. D Plocová's co-authors include Karel Ulbrich, J. Strohalm, Vladimír Šubr, M. Jelı́nková, Blanka Řı́hová, Martin Šťastný, Ondřej Hovorka, Milada Šírová, Mario Novak and P Poučková and has published in prestigious journals such as Journal of Controlled Release, European Journal of Cancer and Bioconjugate Chemistry.

In The Last Decade

D Plocová

19 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Plocová Czechia 15 441 348 212 136 129 19 797
Huaizhong Pan United States 19 523 1.2× 339 1.0× 294 1.4× 191 1.4× 212 1.6× 24 1.1k
Elisabetta Gianasi United Kingdom 8 285 0.6× 294 0.8× 122 0.6× 159 1.2× 69 0.5× 12 677
Libor Kostka Czechia 18 381 0.9× 382 1.1× 315 1.5× 188 1.4× 113 0.9× 47 925
Pooja Chandna United States 9 473 1.1× 570 1.6× 252 1.2× 118 0.9× 111 0.9× 9 945
Bryan Hoang Canada 13 636 1.4× 289 0.8× 452 2.1× 122 0.9× 150 1.2× 17 985
Jane-Guo Shiah United States 11 360 0.8× 269 0.8× 303 1.4× 118 0.9× 108 0.8× 13 687
Milada Šírová Czechia 21 808 1.8× 396 1.1× 495 2.3× 273 2.0× 157 1.2× 45 1.2k
Dina Polyak Israel 11 313 0.7× 300 0.9× 216 1.0× 64 0.5× 130 1.0× 21 681
Aaron P. Griset United States 9 384 0.9× 498 1.4× 288 1.4× 173 1.3× 112 0.9× 13 1.3k
Elaine H. Moase Canada 14 640 1.5× 807 2.3× 273 1.3× 56 0.4× 149 1.2× 18 1.2k

Countries citing papers authored by D Plocová

Since Specialization
Citations

This map shows the geographic impact of D Plocová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Plocová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Plocová more than expected).

Fields of papers citing papers by D Plocová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Plocová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Plocová. The network helps show where D Plocová may publish in the future.

Co-authorship network of co-authors of D Plocová

This figure shows the co-authorship network connecting the top 25 collaborators of D Plocová. A scholar is included among the top collaborators of D Plocová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Plocová. D Plocová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Řı́hová, Blanka, J. Strohalm, Ondřej Hovorka, et al.. (2008). Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences. Journal of Controlled Release. 127(2). 110–120. 23 indexed citations
2.
Šírová, Milada, J. Strohalm, Vladimír Šubr, et al.. (2006). Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice. Cancer Immunology Immunotherapy. 56(1). 35–47. 54 indexed citations
3.
Poučková, P, M Zadinová, J. Strohalm, et al.. (2004). Polymer-conjugated bovine pancreatic and seminal ribonucleases inhibit growth of human tumors in nude mice. Journal of Controlled Release. 95(1). 83–92. 23 indexed citations
4.
Souček, J., P Poučková, J. Strohalm, et al.. (2002). Poly [N -(2-hydroxypropyl)methacrylamide] Conjugates of Bovine Pancreatic Ribonuclease (RNase A) Inhibit Growth of Human Melanoma in Nude Mice. Journal of drug targeting. 10(3). 175–183. 23 indexed citations
5.
Šťastný, Martin, D Plocová, Tomáš Etrych, Karel Ulbrich, & Blanka Řı́hová. (2002). HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia. European Journal of Cancer. 38(4). 602–608. 22 indexed citations
6.
Řı́hová, Blanka, J. Strohalm, Kateřina Kubáčková, et al.. (2002). Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs. Journal of Controlled Release. 78(1-3). 97–114. 43 indexed citations
7.
Souček, J., P Poučková, M Zadinová, et al.. (2001). Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.. PubMed. 48(2). 127–32. 7 indexed citations
8.
Řı́hová, Blanka, J. Strohalm, M. Jelı́nková, et al.. (2001). Immunoprotective therapy with targeted anticancer drugs. Macromolecular Symposia. 172(1). 21–28. 27 indexed citations
9.
Řı́hová, Blanka, M. Jelı́nková, J. Strohalm, et al.. (2000). Polymeric drugs based on conjugates of synthetic and natural macromolecules.. Journal of Controlled Release. 64(1-3). 241–261. 85 indexed citations
10.
Ulbrich, Karel, et al.. (2000). Polymeric drugs based on conjugates of synthetic and natural macromolecules. Journal of Controlled Release. 64(1-3). 63–79. 306 indexed citations
11.
Ulbrich, Karel, J. Strohalm, D Plocová, et al.. (2000). Poly[N-(2-Hydroypropyl)Methacrylamide] Conjugates of Bovine Seminal Ribonuclease. Synthesis, Physicochemical, and Preliminary Biological Evaluation. Journal of Bioactive and Compatible Polymers. 15(1). 4–26. 2 indexed citations
12.
Ulbrich, Karel, J. Strohalm, D Plocová, et al.. (2000). Poly[N-(2-hydroxypropyl)meth-acrylamide] Conjugates of Bovine Seminal Ribonuclease. Synthesis, Physicochemical, and Preliminary Biological Evaluation. Journal of Bioactive and Compatible Polymers. 15(1). 4–26. 21 indexed citations
13.
14.
Šťastný, Martin, J. Strohalm, D Plocová, Karel Ulbrich, & Blanka Řı́hová. (1999). A Possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier. European Journal of Cancer. 35(3). 459–466. 46 indexed citations
15.
Jelı́nková, M., J. Strohalm, D Plocová, et al.. (1998). Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigens. Journal of Controlled Release. 52(3). 253–270. 35 indexed citations
16.
Řı́hová, Blanka, J. Strohalm, D Plocová, et al.. (1996). Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin A. Journal of Controlled Release. 40(3). 303–319. 24 indexed citations
17.
Vetvicka, V, et al.. (1990). Properties of macrophages from high- and low-responder strains of mice. II. The expression of Fc receptors.. PubMed. 36(5). 216–30. 1 indexed citations
18.
Větvička, Václav, et al.. (1989). Different handling of antigen by macrophages of low-responder C57BL/10ScSn strain and high-responder A/J strain of mice. II. Antigen uptake.. PubMed. 35(2). 90–101. 1 indexed citations
19.
Plocová, D, et al.. (1986). The Activity of Complement in the Presence of N-(2-hydroxypropyl)methacrylamide Copolymers. Journal of Bioactive and Compatible Polymers. 1(1). 20–31. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaizhong Pan Breakdown of academic impact, for papers by Elisabetta Gianasi Breakdown of academic impact, for papers by Libor Kostka Breakdown of academic impact, for papers by Pooja Chandna Breakdown of academic impact, for papers by Bryan Hoang Breakdown of academic impact, for papers by Jane-Guo Shiah Breakdown of academic impact, for papers by Milada Šírová Breakdown of academic impact, for papers by Dina Polyak Breakdown of academic impact, for papers by Aaron P. Griset Breakdown of academic impact, for papers by Elaine H. Moase
Rankless by CCL
2026